Assenagon Asset Management S.A. Cuts Stock Position in AngioDynamics, Inc. $ANGO

Assenagon Asset Management S.A. cut its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 88.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,727 shares of the medical instruments supplier’s stock after selling 209,353 shares during the quarter. Assenagon Asset Management S.A. owned 0.07% of AngioDynamics worth $315,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Farther Finance Advisors LLC lifted its stake in shares of AngioDynamics by 146.4% in the 4th quarter. Farther Finance Advisors LLC now owns 2,018 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 1,199 shares during the period. Kemnay Advisory Services Inc. acquired a new position in shares of AngioDynamics during the fourth quarter worth about $27,000. State of Wyoming purchased a new position in AngioDynamics during the second quarter worth about $31,000. Russell Investments Group Ltd. raised its holdings in AngioDynamics by 329.5% during the third quarter. Russell Investments Group Ltd. now owns 4,188 shares of the medical instruments supplier’s stock worth $47,000 after purchasing an additional 3,213 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in AngioDynamics by 359.0% in the second quarter. Tower Research Capital LLC TRC now owns 5,457 shares of the medical instruments supplier’s stock valued at $54,000 after purchasing an additional 4,268 shares during the period. 89.43% of the stock is currently owned by hedge funds and other institutional investors.

AngioDynamics Stock Performance

Shares of ANGO stock opened at $13.09 on Friday. The firm has a 50-day moving average price of $11.80 and a 200 day moving average price of $11.36. AngioDynamics, Inc. has a twelve month low of $8.36 and a twelve month high of $13.99. The company has a market capitalization of $540.88 million, a price-to-earnings ratio of -17.45 and a beta of 0.34.

AngioDynamics (NASDAQ:ANGO) last released its quarterly earnings results on Thursday, April 2nd. The medical instruments supplier reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.04. The company had revenue of $78.42 million for the quarter, compared to analysts’ expectations of $76.77 million. AngioDynamics had a negative net margin of 10.01% and a negative return on equity of 4.66%. As a group, research analysts predict that AngioDynamics, Inc. will post -0.19 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ANGO shares. Freedom Capital raised AngioDynamics to a “strong-buy” rating in a report on Monday, April 6th. Weiss Ratings restated a “sell (d-)” rating on shares of AngioDynamics in a research note on Monday, April 20th. Canaccord Genuity Group dropped their price objective on AngioDynamics from $18.00 to $16.00 and set a “buy” rating on the stock in a report on Monday, April 6th. Finally, Zacks Research cut AngioDynamics from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $18.67.

AngioDynamics Company Profile

AngioDynamics, Inc is a medical technology company headquartered in Latham, New York, that develops, manufactures and markets a broad range of minimally invasive medical devices. The company’s products focus on three core areas: vascular access, peripheral vascular intervention and interventional oncology. Its solutions are designed to improve procedural outcomes, reduce complications and enhance patient comfort in hospital and outpatient settings.

In the vascular access segment, AngioDynamics offers a portfolio of devices including implanted ports, peripherally inserted central catheters (PICCs), hemodialysis catheters and specialty blood management products.